Anti-AN13A/ ANKRD13A/ ANKRD13 monoclonal antibody

Anti-AN13A/ ANKRD13A/ ANKRD13 antibody for FACS & in-vivo assay

Target products collectionGo to ANKRD13A/ANKRD13A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1990-Ab-1/ GM-Tg-hg-MP1990-Ab-2Anti-Human ANKRD13A monoclonal antibodyHuman
GM-Tg-rg-MP1990-Ab-1/ GM-Tg-rg-MP1990-Ab-2Anti-Rat ANKRD13A monoclonal antibodyRat
GM-Tg-mg-MP1990-Ab-1/ GM-Tg-mg-MP1990-Ab-2Anti-Mouse ANKRD13A monoclonal antibodyMouse
GM-Tg-cynog-MP1990-Ab-1/ GM-Tg-cynog-MP1990-Ab-2Anti-Cynomolgus/ Rhesus macaque ANKRD13A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1990-Ab-1/ GM-Tg-felg-MP1990-Ab-2Anti-Feline ANKRD13A monoclonal antibodyFeline
GM-Tg-cang-MP1990-Ab-1/ GM-Tg-cang-MP1990-Ab-2Anti-Canine ANKRD13A monoclonal antibodyCanine
GM-Tg-bovg-MP1990-Ab-1/ GM-Tg-bovg-MP1990-Ab-2Anti-Bovine ANKRD13A monoclonal antibodyBovine
GM-Tg-equg-MP1990-Ab-1/ GM-Tg-equg-MP1990-Ab-2Anti-Equine ANKRD13A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1990-Ab-1/ GM-Tg-hg-MP1990-Ab-2; GM-Tg-rg-MP1990-Ab-1/ GM-Tg-rg-MP1990-Ab-2;
GM-Tg-mg-MP1990-Ab-1/ GM-Tg-mg-MP1990-Ab-2; GM-Tg-cynog-MP1990-Ab-1/ GM-Tg-cynog-MP1990-Ab-2;
GM-Tg-felg-MP1990-Ab-1/ GM-Tg-felg-MP1990-Ab-2; GM-Tg-cang-MP1990-Ab-1/ GM-Tg-cang-MP1990-Ab-2;
GM-Tg-bovg-MP1990-Ab-1/ GM-Tg-bovg-MP1990-Ab-2; GM-Tg-equg-MP1990-Ab-1/ GM-Tg-equg-MP1990-Ab-2
Products NameAnti-ANKRD13A monoclonal antibody
Formatmab
Target NameANKRD13A
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ANKRD13A benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species AN13A/ ANKRD13A/ ANKRD13 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm004052mouse Ankrd13a Lentivirus plasmid
    ORF Viral VectorvGMLPm004052mouse Ankrd13a Lentivirus particle


    Target information

    Target IDGM-MP1990
    Target NameANKRD13A
    Gene ID88455,68420,360823,708383,609384,101084139,511883,100066442
    Gene Symbol and Synonyms1100001D10Rik,ANKRD13,ANKRD13A,NY-REN-25
    Uniprot AccessionQ8IZ07
    Uniprot Entry NameAN13A_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000076513
    Target ClassificationN/A

    The target: ANKRD13A, gene name: ANKRD13A, also named as ANKRD13, NY-REN-25. Enables ubiquitin-dependent protein binding activity. Involved in negative regulation of protein localization to endosome and negative regulation of receptor internalization. Located in late endosome; perinuclear region of cytoplasm; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.